Genetic analysis of benign ovarian tumors

被引:23
作者
Thomas, NA
Neville, PJ
Baxter, SW
Campbell, IG
机构
[1] Peter MacCallum Canc Inst, VBCRC Canc Genet Lab, Melbourne, Vic 8006, Australia
[2] Princess Anne Hosp, Dept Obstet & Gynecol, Southampton, Hants, England
关键词
benign ovarian tumors; loss of heterozygosity; mutation analysis; tumor suppressor genes; TP53; K-ras;
D O I
10.1002/ijc.11107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer represents a major cause of cancer death among women and yet remarkably little is known about its etiology. The paradigm established by the colorectal carcinogenesis model would suggest that ovarian cancers are likely to arise through malignant transformation of benign ovarian tumors. However, molecular genetic data that could answer this important question is lacking. In our study, we analyzed 80 benign ovarian tumors for TP53 and K-ras mutations and for LOH on chromosomes 6, 7, 9, 11 and 17 using 56 microsatellite markers. Twenty-five percent (5/20) of non-epithelial tumors and 73% (44/60) of epithelial tumors exhibited LOH on at least 1 chromosome arm. A particularly high frequency of LOH was detected among the epithelial tumors on chromosome arms 6q (17%), 7p (17%), 7q (27%) and 11p (18%), which are also regions of frequent LOH among ovarian carcinomas. No K-ras mutations were detected in any tumor but somatic TP53 mutations were detected in 2/34 (6%) serous and 1/26 (4%) mucinous epithelial tumors. In contrast to most previous studies our data is derived from a relatively large number of microdissected tumors and is likely to represent a more accurate picture of the frequency of alterations in these tumors. We conclude that LOH is common in benign ovarian tumors, suggesting that inactivation of tumor suppressor genes are pivotal in their development. The high frequency of alterations is consistent with their being precursors to malignant disease but does not unequivocally prove this continuum. It does however provide a framework for future analysis of the molecular genetic etiology of ovarian tumorigenesis. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:499 / 505
页数:7
相关论文
共 50 条
  • [41] Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers
    Catherine Genestie
    Aurélie Auguste
    Miriam Al Battal
    Jean-Yves Scoazec
    Sébastien Gouy
    Ludovic Lacroix
    Philippe Morice
    Patricia Pautier
    Alexandra Leary
    Mojgan Devouassoux-Shisheboran
    [J]. Virchows Archiv, 2021, 478 : 885 - 891
  • [42] Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers
    Genestie, Catherine
    Auguste, Aurelie
    Al Battal, Miriam
    Scoazec, Jean-Yves
    Gouy, Sebastien
    Lacroix, Ludovic
    Morice, Philippe
    Pautier, Patricia
    Leary, Alexandra
    Devouassoux-Shisheboran, Mojgan
    [J]. VIRCHOWS ARCHIV, 2021, 478 (05) : 885 - 891
  • [43] Factors associated with oophorectomy in children with benign ovarian masses
    Kapp, Daniel S.
    Rosenfeld, Emily B.
    Chan, Joshua E.
    Chan, John K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 138 (03) : 356 - 357
  • [44] A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis
    Longacre, Mckenna
    Snyder, Nicole A.
    Housman, Genevieve
    Leary, Meghan
    Lapinska, Karolina
    Heerboth, Sarah
    Willbanks, Amber
    Sarkar, Sibaji
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [45] CHROMOSOME-11 ALLELE IMBALANCE AND CLINICOPATHOLOGICAL CORRELATES IN OVARIAN-TUMORS
    GABRA, H
    TAYLOR, L
    COHEN, BB
    LESSELS, A
    ECCLES, DM
    LEONARD, RCF
    SMYTH, JF
    STEEL, CM
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 367 - 375
  • [46] Defining a Molecular Phenotype for Benign and Malignant Parathyroid Tumors
    Fernandez-Ranvier, Gustavo G.
    Khanafshar, Elham
    Tacha, David
    Wong, Mariwil
    Kebebew, Electron
    Duh, Quan-Yang
    Clark, Orlo H.
    [J]. CANCER, 2009, 115 (02) : 334 - 344
  • [47] RAS ONCOGENE ACTIVATION IN BENIGN AND MALIGNANT COLORECTAL TUMORS
    SPANDIDOS, DA
    GLARAKIS, IS
    KOTSINAS, A
    ERGAZAKI, M
    KIARIS, H
    [J]. TUMORI, 1995, 81 (03) : 7 - 11
  • [48] Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors
    Emerson, Robert E.
    Wang, Mingsheng
    Roth, Lawrence M.
    Zheng, Wenxin
    Abdul-Karim, Fadi W.
    Liu, Fang
    Ulbright, Thomas M.
    Eble, John N.
    Cheng, Liang
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2007, 26 (04) : 368 - 374
  • [49] The molecular pathology of ovarian serous borderline tumors
    Malpica, A.
    Wong, K. -K.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 16 - 19
  • [50] Women's fertility after laparoscopic cystectomy of endometrioma and other benign ovarian tumors - a 24-month follow-up retrospective study
    Kostrzewa, Marta
    Stachowiak, Grzegorz
    Zyla, Monika
    Kolasa-Zwierzchowska, Dorota
    Szpakowski, Artur
    Nowak, Marek
    Wilczynski, Jacek R.
    [J]. NEUROENDOCRINOLOGY LETTERS, 2016, 37 (04) : 295 - 300